Issue Fee. On the Effective Date, Licensee will pay to Penn a one-time, non-refundable payment of […***…]. Such payment will be made by wire transfer of immediately available funds into the account specified in Section 4.5.
Appears in 3 contracts
Sources: Research, Collaboration & License Agreement (Ultragenyx Pharmaceutical Inc.), Research, Collaboration & License Agreement (Dimension Therapeutics, Inc.), Research, Collaboration & License Agreement (Dimension Therapeutics, Inc.)